Data / Form D filings / StimuSIL, Inc.
StimuSIL, Inc.: Form D filings
StimuSIL, Inc., a biotechnology company in Wilmington, DE, filed 5 Form D notices with the SEC between 2022 and 2025. The latest, on March 7, 2025, reports $599,988 sold of a $599,988 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2810 Church Street, PMB 78535, Wilmington, DE, 19802
- Phone
- +49 (176) 3011 2000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1939123
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | New notice | $599,988 | $599,988 | 2 | Dec 31, 2024 | sec.gov | |
| May 10, 2024 | New notice | $1,103,787 | $1,103,787 | 7 | Apr 8, 2024 | sec.gov | |
| Sep 13, 2023 | New notice | $48,799 | $48,799 | 1 | Aug 31, 2023 | sec.gov | |
| Aug 30, 2022 | Amendment | $574,998 | $574,998 | 12 | Jul 1, 2022 | sec.gov | |
| Aug 12, 2022 | New notice | $569,734 | $569,734 | 11 | Jul 1, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Abidin Gulmus | Director | |
| Ana Villalba Villar | Executive Officer, Director | |
| Pablo Villalba | Executive Officer, Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Mar 3, 2025 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what StimuSIL, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.